1. Variable duration of viral shedding in cancer patients with coronavirus disease 2019 (COVID-19)
- Author
-
Tracy McMillen, Ying Taur, Krupa Jani, Karin Chow, N. Esther Babady, Mini Kamboj, Tara McClure, Bevin Cohen, Monika K. Shah, Elizabeth Robilotti, Mario Caldararo, and Anoshe Aslam
- Subjects
Microbiology (medical) ,Oncology ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Epidemiology ,viruses ,SARS CoV-2 ,medicine.disease_cause ,Virus ,Neoplasms ,Internal medicine ,medicine ,Humans ,Respiratory system ,Viral shedding ,Cancer ,Retrospective Studies ,Coronavirus ,SARS-CoV-2 ,business.industry ,Public health ,COVID-19 ,Retrospective cohort study ,medicine.disease ,Virus Shedding ,body regions ,Infectious Diseases ,RNA, Viral ,Original Article ,business - Abstract
In this retrospective study of 105 severe acute respiratory coronavirus virus 2 (SARS-CoV-2)–infected cancer patients with longitudinal nasopharyngeal sampling, the duration of viral shedding and time to attain cycle threshold >30 was longer in patients with hematologic malignancy than in those with solid tumors. These findings have important public health implications.
- Published
- 2021
- Full Text
- View/download PDF